Table 5.
Details of 12 adult split liver retransplants (reLTX) in this series with observed patient and graft survival as well as the indications for the primary liver transplant procedures (LTX) and the retransplant procedures (reLTX) and the time intervals between LTX and reLTX in days
| Recipient sex | Time between LTX and reLTX (days) | Indication for primary LTX | Indication for reLTX | Transplanted segments (reLTX) | Death during the observation period | Patient survival (year) | Graft survival (year) |
|---|---|---|---|---|---|---|---|
| F | 47 | Cryptogenic cirrhosis | Biliary tract complications | 5–8 | Yes | 1.1 | 0.8 |
| F | 37 | PBC | Initial graft non-function | 1–4 | Yes | 9.0 | 0.1 |
| M | 1,159 | HBV HCV-related cirrhosis | Biliary tract complications | 4–8 | Yes | 0.1 | 0.1 |
| F | 10 | PSC | Biliary tract complications | 5–8+1 | Yes | 0.0 | 0.0 |
| F | 7 | HCC | Acute rejection | 5–8+1 | Yes | 0.2 | 0.2 |
| M | 666 | PSC | Chronic graft failure | 4–8+1 | No | 12.1 | 12.1 |
| F | 4,122 | Bylers disease | Chronic graft failure | 4–8+1 | No | 7.5 | 7.5 |
| F | 253 | HBV HDV-related cirrhosis | Biliary tract complications | 5–8+1 | No | 7.2 | 7.2 |
| M | 20 | Budd Chiari syndrome | Hepatic Artery thrombosis | 4–8+1 | No | 7.1 | 7.1 |
| M | 3 | HCC | Hepatic Artery thrombosis | 4–8+1 | Yes | 0.1 | 0.1 |
| M | 5,058 | Caroli syndrome | Chronic graft failure | 5–8 | No | 1.4 | 1.4 |
| M | 2 | Alcoholic cirrhosis | Initial graft nonfunction | 4–8+1 | Yes | 3.5 | 3.5 |
All primary transplants were performed with whole organ grafts
F female, M male, HCC hepatocellular carcinoma, HDV hepatitis D virus, PSC primary sclerosing cholangitis